샘플 요청 목록

 카트 문의
시장보고서
상품코드
1514194

세계의 조영제 시장

Imaging Agents
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 184 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 조영제 시장은 2030년까지 미국에서 134억 달러에 달할 전망

2023년에 98억 달러로 평가된 세계의 조영제 시장은 분석 기간 2023년부터 2030년까지 연평균 복합 성장률(CAGR) 4.5%로 성장할 전망이며, 2030년에는 134억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 진단용 방사성 의약품은 CAGR 5.9%로 성장을 지속하고, 분석 기간 종료 시에는 72억 달러에 달할 것으로 예측됩니다. X선/CT 분야의 성장률은 분석 기간 중 CAGR 3.3%로 추정됩니다.

미국 시장은 27억 달러, 중국은 CAGR 7.9%로 성장 예측

미국의 조영제 시장은 2023년 27억 달러로 평가되었습니다. 세계 2위 경제대국인 중국은 2030년까지 29억 달러 규모에 이를 것으로 예측되며, 분석 기간 2023년부터 2030년까지 CAGR은 7.9%로 전망됩니다. 다른 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.3%와 3.8%로 예측되고 있습니다. 유럽에서는 독일이 CAGR 3.0%로 성장할 것으로 예측됩니다.

세계의 조영제 시장-주요 동향 및 촉진요인 요약

진단용 조영제(조영제)는 질병 진단을 위한 이미징 과정을 강화하기 위해 환자에게 투여되는 물질입니다. 이러한 약제는 X선, 감마선, 음파, 라디오파(MRI), 방사성 입자 등 다양한 방법으로 방사성 의약품이 에너지를 방출하는 데 도움이 됩니다. 이미지의 콘트라스트를 향상시켜 건강 관리 전문가가 신체의 구조를 더 잘 시각화하고 평가하고, 이상을 감지할 수 있게 하고, 정확한 진단을 위한 중요한 인사이트를 제공합니다. 의료 이미지는 의사가 암에서 뇌졸중까지 다양한 질병을 진단하는 데 도움이되며 수백만 명의 생명을 구하는 중요한 도구입니다. 이 분야를 형성하는 가장 영향력 있는 동향 중 하나가 인공지능(AI)입니다.

의료 영상 진단의 기술적 진보는 잠재력을 지속적으로 확대하여 더욱 빠르고 안전하며 효율적인 영상 진단으로 이어지고 있습니다. 각 회사는 첨단 기술과 세계적으로 인정된 안전 프로토콜을 활용하여 종합적인 이미징 솔루션을 제공합니다. 이미징 진보의 주요 원동력에는 AI, 머신러닝, 딥러닝이 포함됩니다. 이러한 기술은 CT 스캔, MRI, 초음파 검사에 통합되어 거의 완벽한 정확도로 반복 작업을 자동화하고 기존 방법에 비해 비용을 절감합니다. 의료 전문가들은 위험을 평가하고 치료를 조정하며 최적의 비용 효율적인 치료를 보장하기 위해 점점 AI 기반 솔루션에 의존하고 있습니다. 3D 의료 영상 기술의 가상현실과 증강현실(VR/AR)은 2D MRI 및 CT 스캔에서 3D 영상을 생성하여 복잡한 구조의 시각화를 강화합니다. VR/AR 시장은 아직 발전 도상이지만, 헬스케어에 있어서 그 변혁의 가능성은 밝혀지고 있습니다.

핵의학 이미징과 착용가능한 기술은 또한 의료 영상의 진보를 촉진하고 있습니다. 핵의학 이미징에서는 방사성 트레이서를 사용하여 암이나 알츠하이머병 등 체내 상태에 대한 상세한 인사이트를 제공하고, EXPLORER 전신 PET/CT 스캐너와 같은 장치가 효율을 향상시키고 있습니다. 웨어러블은 HD-DOT 장치 및 웨어러블 초음파 스캐너를 통해 뇌와 장기의 지속적인 모니터링을 가능하게 하는 등 방사선 의학에 새로운 용도을 제공합니다. 이러한 혁신은 진단 능력을 확대하고 조기 발견과 더 효과적인 치료를 제공함으로써 환자의 치료를 개선하고 있습니다.

조사 대상 기업 예(주목의 23사)

  • Aytu BioScience Inc.
  • Bayer Healthcare Pharmaceuticals
  • Bracco Diagnostics Inc.
  • Curium
  • Daiichi Sankyo Company Limited
  • Eli Lilly
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging Inc.
  • Piramal Imaging SA

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향 및 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

AJY 24.07.24

Global Imaging Agents Market to Reach US$13.4 Billion by 2030

The global market for Imaging Agents estimated at US$9.8 Billion in the year 2023, is expected to reach US$13.4 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Diagnostic Radiopharmaceuticals, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$7.2 Billion by the end of the analysis period. Growth in the X-Ray / CT segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 7.9% CAGR

The Imaging Agents market in the U.S. is estimated at US$2.7 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2030 trailing a CAGR of 7.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Imaging Agents Market - Key Trends and Drivers Summarized

Diagnostic imaging agents, or contrast agents, are substances administered to patients to enhance the imaging process for disease diagnosis. These agents help radiopharmaceuticals emit energy using various methods, such as X-rays, gamma rays, sound waves, radio waves (MRI), and radioactive particles. By improving image contrast, they enable healthcare professionals to better visualize and assess body structures and detect abnormalities, providing critical insights for accurate diagnosis. Medical imaging is a critical tool that saves millions of lives by helping doctors diagnose diseases ranging from cancer to stroke. One of the most influential trends shaping this field is artificial intelligence (AI).

Technological progress in medical imaging continues to expand possibilities, leading to faster, safer, and more efficient imaging. Companies leverage advanced technology and globally accepted safety protocols to offer comprehensive imaging solutions. Key drivers in imaging advancements include AI, machine learning, and deep learning. These technologies are integrated into CT scans, MRIs, and ultrasounds to automate repetitive tasks with nearly perfect accuracy, cutting costs compared to traditional methods. Healthcare professionals increasingly rely on AI-based solutions to assess risk and tailor treatments, ensuring optimal, cost-effective therapy. Virtual and augmented reality (VR/AR) in 3D medical imaging technologies provide physicians with enhanced visualization of complex structures by creating 3D images from 2D MRI or CT scans. While the VR/AR market is still developing, its transformative potential in healthcare is becoming evident.

Nuclear imaging and wearable technology are also driving advancements in medical imaging. Nuclear imaging uses radiotracers to provide detailed insights into internal conditions such as cancer and Alzheimer's disease, with devices like the EXPLORER Total-body PET/CT Scanner improving efficiency. Wearables offer new applications in radiology, with the HD-DOT instrument and wearable ultrasound scanners enabling continuous brain and organ monitoring. These innovations are expanding diagnostic capabilities and improving patient care by providing earlier detection and more effective treatments.

Select Competitors (Total 23 Featured) -

  • Aytu BioScience Inc.
  • Bayer Healthcare Pharmaceuticals
  • Bracco Diagnostics Inc.
  • Curium
  • Daiichi Sankyo Company Limited
  • Eli Lilly
  • GE Healthcare
  • Guerbet Group
  • Lantheus Medical Imaging Inc.
  • Piramal Imaging SA

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Imaging Agents - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Drives Demand for Enhanced Diagnostic Imaging
    • Nanotechnology Innovations Open New Frontiers in Imaging Agent Efficacy
    • Expansion of Personalized Medicine Strengthens the Business Case for Targeted Imaging Agents
    • Aging Global Population Increases Utilization of Imaging Services
    • Technological Advancements in Imaging Equipment Spur Demand for Compatible Agents
    • Safety Concerns and Side Effects Prompt Research into Alternative Imaging Agents
    • Rise of Theranostics Integrates Diagnostic and Therapeutic Capabilities in Single Agents
    • Growing Healthcare Expenditure Worldwide Expands Addressable Market for Imaging Agents
    • Emergence of Multi-modal Imaging Techniques Catalyzes Innovations in Agent Development
    • Shift Towards Minimally Invasive Procedures Enhances the Role of Imaging Agents
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Imaging Agents Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Imaging Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Radiopharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Diagnostic Radiopharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for X-Ray / CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for X-Ray / CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for X-Ray / CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Canada 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • JAPAN
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Japan 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • CHINA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: China 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • EUROPE
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Imaging Agents by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Europe 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • FRANCE
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: France 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • GERMANY
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Germany 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Italy 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: UK 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 47: Spain Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Spain Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Spain 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 50: Russia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Russia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Russia 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Rest of Europe 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Imaging Agents by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Asia-Pacific 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 59: Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Asia-Pacific Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Asia-Pacific 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 62: Australia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Australia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Australia 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • INDIA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 65: India Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: India Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: India 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 68: South Korea Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: South Korea Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: South Korea 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 71: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Rest of Asia-Pacific Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Rest of Asia-Pacific 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Imaging Agents by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Latin America 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 77: Latin America Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Latin America Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Latin America 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 80: Argentina Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Argentina Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Argentina 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 83: Brazil Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Brazil Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Brazil 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 86: Mexico Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Mexico Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Mexico 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 89: Rest of Latin America Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Latin America Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Latin America 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Imaging Agents by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Middle East 16-Year Perspective for Imaging Agents by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 95: Middle East Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Middle East Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Middle East 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 98: Iran Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Iran Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Iran 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 101: Israel Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Israel Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Israel 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 104: Saudi Arabia Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Saudi Arabia Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Saudi Arabia 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 107: UAE Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UAE Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UAE 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 110: Rest of Middle East Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Rest of Middle East Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Rest of Middle East 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030
  • AFRICA
    • Imaging Agents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 113: Africa Recent Past, Current & Future Analysis for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Africa Historic Review for Imaging Agents by Product Segment - Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Africa 16-Year Perspective for Imaging Agents by Product Segment - Percentage Breakdown of Value Sales for Diagnostic Radiopharmaceuticals, X-Ray / CT, MRI and Ultrasound for the Years 2014, 2024 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제